Worldly Partners Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$520K Sell
115,798
-1
-0% -$7 0.42% 3
2026
Q1
$1.22M Hold
115,799
1.03% 3
2025
Q4
$1.33M Hold
115,799
0.99% 3
2025
Q3
$2.81M Hold
115,799
1.68% 3
2025
Q2
$1.9M Hold
115,799
1.04% 3
2025
Q1
$2.11M Hold
115,799
1.19% 3
2024
Q4
$4.3M Hold
115,799
2.25% 3
2024
Q3
$3.71M Hold
115,799
1.76% 3
2024
Q2
$9.51M Hold
115,799
5.1% 3
2024
Q1
$16.8M Hold
115,799
7.91% 3
2023
Q4
$10.7M Buy
115,799
+16,111
+16% +$1.64M 5.92% 3
2023
Q3
$16.4M Buy
99,688
+1,859
+2% +$242K 10.5% 3
2023
Q2
$6.18M Hold
97,829
3.54% 3
2023
Q1
$3.32M Hold
97,829
2.1% 4
2022
Q4
$5.65M Buy
+97,829
New +$6.04M 4.4% 3

Other funds holding CDLX

Worldly Partners Management's CDLX Position: Q2 2026 in Review

Worldly Partners Management reduced its Cardlytics (CDLX) stake by 0% in Q2 2026, selling an estimated $7 and leaving 115,798 shares worth $520K. The position accounts for 0.42% of the portfolio, ranked #3.

Worldly Partners Management first reported a position in CDLX in Q4 2022 and has held it in 15 quarters since. The position peaked at $16.8M in Q1 2024. 41 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Worldly Partners Management held 115,798 shares of Cardlytics worth $520K as of Q2 2026.
  • Worldly Partners Management sold 1 Cardlytics share in Q2 2026, an estimated $7.
  • Cardlytics made up 0.42% of Worldly Partners Management's portfolio in Q2 2026, its #3 holding.
  • Worldly Partners Management first reported a position in Cardlytics in Q4 2022 and has held it in 15 quarters since.
  • Worldly Partners Management's Cardlytics position peaked at $16.8M in Q1 2024.
  • 41 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Worldly Partners Management's 13F filing for Q2 2026, filed 7 Aug 2026.